FP-1039 - Five Prime
Five Prime Therapeutics: Q2 2015 Results (Five Prime Therap) - Aug 11, 2015 - Anticipated preliminary data from P1b trial for squamous NSCLC and mesothelioma at WCLC (Sep 6-9, 2015) 
Anticipated P1 data • Non Small Cell Lung Cancer • Oncology
http://investor.fiveprime.com/releasedetail.cfm?ReleaseID=926458
 
Aug 11, 2015
 
.